University Hospital Birmingham — Birmingham

Public research footprint of University Hospital Birmingham, compiled from the ClinicalTrials.gov public registry.

116

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Haematological Malignancy · Cancer · Solid Tumour · Melanoma

Recently updated registry entries

NCT04554914 — A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV)… (Active Not Recruiting)
NCT06745908 — Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and… (Recruiting)
NCT04619004 — HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospital Birmingham?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.